Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transplantation of patient-specific bile duct bioengineered with chemically reprogrammed and microtopographically differentiated cells

ABSTRACT: Transplantation of patient-specific bile duct bioengineered with chemically reprogrammed and microtopographically differentiated cells

PROVIDER: PRJNA640529 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR12053483_1.fastq.gz	Fastqsanger.gz
	SRR12053483_2.fastq.gz	Fastqsanger.gz
	SRR12053484_1.fastq.gz	Fastqsanger.gz
	SRR12053484_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 4 of 4

Similar Datasets

Transplantation of patient-specific bile duct bioengineered with chemically reprogrammed and microtopographically differentiated cells

Project description:Cholangiopathy is a diverse spectrum of chronic progressive bile duct disorders with limited treatment options and dismal outcome. Scaffold- and stem cell-based tissue engineering technologies hold great promise for the reconstructive surgery and tissue repair. Here, we report a combined application of 3D scaffold fabrication and direct reprogramming of the patient-specific human hepatocytes to a population of pluripotent stem cells to fabricate implantable artificial tissues that imitate mechanical and biological properties of the native bile ducts. The chemically derived hepatic progenitor cells (hCdHs) were generated using two small molecules A8301 and CHIR99021 and seeded inside the tubular scaffold engineered as synergistic combination of two layers. The inner electrospun fibrous layer was made of nanoscale-macroscale polycaprolactone fibers acting to promote the hCdHs attachment, alignment, and differentiation, while the outer microporous acellular foam layer served to increase mechanical stability. The two layers of fiber and foam were fused robustly together thus creating a coordinated mechanical flexibility to exclude any possible breaking or tear during surgery. The gene expression profiling and histochemical assessment confirmed that hCdHs acquired the biliary epithelial phenotype and filled the entire volume surface of fibrous matrix after two weeks of growth in cholangiocyte differentiation medium in vitro. The fabricated construct replaced the macroscopic part of the common bile duct (CBD) and re-stored the bile flow in a rabbit model of acute CBD injury. Animals which received the acellular scaffolds did not survive the replacement surgery. Thus, the artificial bile duct constructs populated with the patient-specific hepatic progenitor cells could provide a scalable and compatible platform for treating bile duct diseases.

2021-06-18 | GSE152809 | GEO

Transplantation of patient-specific bile duct bioengineered with chemically reprogrammed and microtopographically differentiated cells.

Project description:Cholangiopathy is a diverse spectrum of chronic progressive bile duct disorders with limited treatment options and dismal outcomes. Scaffold- and stem cell-based tissue engineering technologies hold great promise for reconstructive surgery and tissue repair. Here, we report a combined application of 3D scaffold fabrication and reprogramming of patient-specific human hepatocytes to produce implantable artificial tissues that imitate the mechanical and biological properties of native bile ducts. The human chemically derived hepatic progenitor cells (hCdHs) were generated using two small molecules A83-01 and CHIR99021 and seeded inside the tubular scaffold engineered as a synergistic combination of two layers. The inner electrospun fibrous layer was made of nanoscale-macroscale polycaprolactone fibers acting to promote the hCdHs attachment and differentiation, while the outer microporous foam layer served to increase mechanical stability. The two layers of fiber and foam were fused robustly together thus creating coordinated mechanical flexibility to exclude any possible breaking during surgery. The gene expression profiling and histochemical assessment confirmed that hCdHs acquired the biliary epithelial phenotype and filled the entire surface of the fibrous matrix after 2 weeks of growth in the cholangiocyte differentiation medium in vitro. The fabricated construct replaced the macroscopic part of the common bile duct (CBD) and re-stored the bile flow in a rabbit model of acute CBD injury. Animals that received the acellular scaffolds did not survive after the replacement surgery. Thus, the artificial bile duct constructs populated with patient-specific hepatic progenitor cells could provide a scalable and compatible platform for treating bile duct diseases.

| S-EPMC8780056 | biostudies-literature

Human bile cholangiocyte organoids originate from the extrahepatic bile duct and can repair bile duct scaffolds in vitro

Project description:Cholangiocyte organoids provide a powerful tool for characterizing bile duct epithelium and expanding cholangiocytes for tissue engineering purposes. However, this involves invasively obtained tissue-biopsies via surgery which is not preferential and limits the patient-specific capacities of these cultures. To overcome this, organoid culture were initiated from minimal invasive bile-samples obtained during routine clinical procedures. Characterization revealed that these bile-cholangiocyte organoids originate from the extrahepatic bile duct and are capable to repopulate human extrahepatic bile duct scaffolds. With this, bile duct tissue engineering as well as personalized disease modelling is in sight.

2020-11-19 | GSE156519 | GEO

aCGH for bile duct cancer

Project description:Assays in bile duct cancer patients showed 984 CNVs in 306 CNV regions (CNVR) distributed throughout all 22 chromosomes. Bile duct cancer patients had a mean of 21.8 gains and 19.2 losses of genes, with an average of 35.9 CNVRs per patient. Frequent sites of gains were at chromosomes 22q11.22, 2p11.2-p.11.1, 14q32.33 and 17q12, whereas frequent sites of losses were at 19q12-q13.43. Investigation of CNV in 24 bile duct cancer tissue samples

2013-07-13 | E-GEOD-48835 | biostudies-arrayexpress

Methylation analysis of normal and tumor bile duct samples

Project description:Genome wide DNA methylation profiling of normal and tumor bile duct samples. The Illumina HumanMethylation450 BeadChip was used to obtain DNA methylation profiles across approximately 450,000 CpGs in 138 tumor bile duct samples and 4 normal bile duct samples.

2017-07-03 | GSE89803 | GEO

aCGH for bile duct cancer

2013-07-13 | GSE48835 | GEO

Cholangiocarcinoma tissues VS. corresponding normal bile duct tissues

Project description:To identify miRNAs differentially expressed in cholangiocarcinoma,3 human cholangiocarcinoma and their corresponding normal bile duct tissues were obtained from 3 patients after operation with postoperative pathological diagnosed perihilar or distal biliary cholangiocarcinoma miRNAs expression in human cholangiocarcinoma/normal bile duct samples was measured after operation.Three independent experiments were performed using different patients for each experiment.

2013-06-10 | E-GEOD-47764 | biostudies-arrayexpress

ATAC-seq from bile duct (ENCSR653ZWW)

Project description:ATAC-seq on human bile duct For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

2022-10-16 | GSE215524 | GEO

ATAC-seq from bile duct (ENCSR325NFE)

2022-10-16 | GSE215700 | GEO

ATAC-seq from bile duct (ENCSR174MLD)

2022-10-16 | GSE215655 | GEO